Medistep Healthcare Complete Financial Statements
MEDISTEP • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2025 - 2024
Complete Financial Data Export
Export complete financial statements for Medistep Healthcare (MEDISTEP).
Downloads include all available records across all periods.
For market performance, see the
MEDISTEP stock price today
.
Profitability Ratios
Net Profit Margin
8.00%
2025 data
EBITDA Margin
12.00%
2025 data
Operating Margin
11.00%
2025 data
Return on Assets
17.39%
2025 data
Return on Equity
23.53%
2025 data
Balance Sheet Ratios
Debt to Equity
1.35
2025 data
Equity Ratio
73.91%
2025 data
Asset Turnover
2.17
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-58.0%
Year-over-Year
Net Profit Growth
-50.0%
Year-over-Year
EBITDA Growth
-66.7%
Year-over-Year
Expense Growth
-56.8%
Year-over-Year
Assets Growth
+53.3%
Year-over-Year
Equity Growth
+41.7%
Year-over-Year
Liabilities Growth
+53.3%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-85.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 |
|---|---|---|---|
| Revenue | 21 | 50 | 32 |
| Expenses | 19 | 44 | 28 |
| EBITDA | 2 | 6 | 4 |
| Operating Profit Margin % | 5.00% | 11.00% | 13.00% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 2 | 6 | 4 |
| Tax | 1 | 1 | 1 |
| Net Profit | 2 | 4 | 3 |
| Earnings Per Share (₹) | 1.60 | 4.01 | 19.96 |
Related Pages for Medistep Healthcare
Additional stock information and data for MEDISTEP
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 |
|---|---|---|
| ASSETS | ||
| Total Assets | 23 | 15 |
| Current Assets | 23 | 15 |
| Fixed Assets | 0 | 0 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 23 | 15 |
| LIABILITIES | ||
| Total Liabilities | 23 | 15 |
| Current Liabilities | 0 | 0 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 17 | 12 |
| Share Capital | 11 | 5 |
| Reserves & Surplus | 6 | 7 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | 0 | -7 |
| Investing Activities | 0 | 0 |
| Financing Activities | 1 | 7 |
| Net Cash Flow | 1 | 0 |